Incorporation of a doctor to the R&D&i within the "Torres Quevedo" program

2018 Call


No votes yet
 
Related
Laboratorios Farmacéuticos Rovi, S.A. (“ROVI”) has announced the purchase of Falithrom®, which was owned by Hexal AG (“Hexal”), a company...
1 min
09/01/2019
0 min
06/11/2018